Blog

T1International at the Democratic Caucus Prescription Drug Prices Roundtable

13 Jun 2019, 4:14 p.m. in #insulin4all USA, News & Statements by Adeline (Lina) Umubyeyi

I appreciated the platform that myself and T1International were given to share our experiences and our clear requirements for any proposed solutions. I hope we will soon see a reduction in insulin costs to ensure it is truly affordable for everyone, and that is what we will continue to push for. Read more

T1International’s Advocates Plan Canada Trip to “Birthplace of Insulin”

12 Jun 2019, 8:52 a.m. in #insulin4all USA, News & Statements by T1International

On Friday, June 28, T1International #insulin4all advocates from the United States, in partnership with Health Care Voter, will join in a Caravan to Canada to purchase insulin at a significantly lower cost on the other side of the border. Advocates from T1International’s Minnesota #insulin4all Chapter will gather in Minneapolis, Minnesota and begin their journey. From there, the Chapter will travel to Lansing, Michigan to join the Michigan #insulin4all Chapter, with advocates from numerous other #insulin4all Chapters joining the caravan along the way. Read more

Contact T1International

30 May 2019, 3:57 p.m. in Press Inquiries

For press inquiries, email press@t1international.com. Read more

T1International at the UN UHC Multi-stakeholder Hearing

17 May 2019, 12:31 p.m. in Global Stories, News & Statements by Lauren Lehrer & Karlynn Holland

In particular, we call on pharmaceutical companies to show up with true solutions, not the same empty rhetoric. We are dying. There are solutions. It is times to protect rights of health and treatment for people living with diabetes and all those in desperate need of essential medicine – a vital part of health for all. Read more

Traveling to Canada for Cheaper Insulin

3 May 2019, 12:33 p.m. in #insulin4all USA, Global Stories by Karyn Wofford

I believe if enough people use their voice and demand change, one day I’ll be able to make a simple 10 minute drive to get my medication rather than a two day journey. Until then, I’ll keep digging for loopholes while fighting for long-term solutions, so that I can live my life as normal as possible. Everyone with type 1 diabetes should be able to focus on caring for their condition without extra unnecessary hoops to jump through. Read more

Case Studies from Kenya

25 Apr 2019, 12:23 p.m. in Global Stories by T1International

I was diagnosed with type 1 diabetes in my early 20's, just when I was preparing to join college. Things turned upside down at that time because my parents could not afford to take me to college and at the same time pay for my insulin and all the tests required. I never went to college because of the costs associated with my diabetes. Read more

Reminder: Eli Lilly Has Been Exploiting T1Ds Since 1922

11 Apr 2019, 5:47 p.m. in #insulin4all USA by Audrey Farley

The “business of diabetes” did not spontaneously emerge mid-century. Corporate stakeholders found underhanded ways to profit from diabetic lives before most affected individuals had even obtained their first injection. And now that Congress is investigating insulin manufacturers, it is important to acknowledge the full scope of their involvement. Read more

New Year, New Deductible: Paying $1,000 each Month to Stay Alive

15 Mar 2019, 12:41 p.m. in #insulin4all USA, Global Stories by April Starks

I’m thrilled to see the recent buzz in the media concerning the high insulin costs many diabetics face daily in the USA. I’ve required insulin multiple times a day for 33+ years and I have a high deductible insurance policy which means medical costs, including prescriptions, aren't covered until the deductible is met. I paid $1,003.91 for insulin this month. That cost is what I paid with insurance and a $150 discount card. I pay high amounts during the first few months of every year until I meet my deductible. Read more

T1International Statement on Lilly & Novo's ''Generic Insulin''

4 Mar 2019, 2:32 p.m. in #insulin4all USA, News & Statements by T1International

Patient-led activism is working. Today Eli Lilly announced that in response to criticism of high prices, the company will sell a version of Humalog insulin for half price. We are pleased to see this result after continual and dedicated efforts by non-pharma funded patient advocates to ensure list price of insulin goes down. While half-price is an improvement, it's still an unaffordable price for so many, considering most people need at least 2 vials each month.
Read more

Hard Work Pays Off for #insulin4all Chapters [USA Update]

27 Feb 2019, 9:56 a.m. in #insulin4all USA, News & Statements by T1International

The #insulin4all USA Chapters are building a coordinated movement to ensure insulin is affordable and accessible to all people with type 1 diabetes. Their efforts are leading to real change at both the State and Federal level. Read more